期刊文献+

小剂量糖皮质激素对ⅢA型前列腺炎患者的辅助治疗作用 被引量:2

Adjunctive Therapy of Low Dose Glucocorticoid in Patients With Type Ⅲ A Prostatitis
下载PDF
导出
摘要 目的探讨小剂量糖皮质激素对ⅢA型前列腺炎患者的辅助治疗作用。方法对照组给予常规治疗,研究组在常规治疗基础上加用口服醋酸泼尼松片。比较分析两组ⅢA型前列腺炎患者的治疗效果以及治疗前后的症状改善、生活质量改善程度。结果小剂量糖皮质激素对于ⅢA型前列腺炎的辅助治疗以及改善所出现的不适及生活质量有显著效果,研究组临床疗效显著高于对照组,P<0.05。结论常规治疗基础上加用小剂量糖皮质激素可显著提高ⅢA型前列腺炎患者临床疗效。 Objective To investigate the effect of low dose glucocorticoid on patients with type Ⅲ A prostatitis. Methods The control group was given conventional treatment, the study group was treated with oral Prednisone Acetate Tablets on the basis of routine treatment. To compare the therapeutic effects of two groups of patients with type Ⅲ A prostatitis and to improve the quality of life before and after treatment. Results The effect of small dose glucocorticoid on the treatment of type ⅢA prostatitis and the discomfort and quality of life were significantly improved, The clinical efficacy of the study group was significantly higher than that of the control group,P〈0.05. Conclusion Based on the routine treatment, the use of small doses of glucocorticoids can significantly improve the clinical efficacy of type Ⅲ A prostatitis.
出处 《中国继续医学教育》 2017年第10期142-144,共3页 China Continuing Medical Education
关键词 糖皮质激素 ⅢA型前列腺炎 醋酸泼尼松片 glucocorticoid type Ⅲ A prostatitis prednisone acetate tablets
  • 相关文献

参考文献9

二级参考文献95

  • 1袁涛,姜启全,卞崔冬,桂亚平.慢性前列腺炎心理相关因素调查及分析[J].中国男科学杂志,2005,19(2):45-46. 被引量:35
  • 2Jun-Fu Zhou,Wei-Qiang Xiao,Yi-Chun Zheng,Jie Dong,Shu-Mei Zhang.Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis[J].Asian Journal of Andrology,2006,8(3):317-323. 被引量:15
  • 3张唯力,戴君勇,魏武然,王志刚,冉海涛.超声辐照微泡对大鼠前列腺增生组织通透性的影响[J].中国医学影像技术,2007,23(1):27-30. 被引量:5
  • 4Blumenfeld W, Tucci S, Narayan P. Incidental lymphecytic prostatitis. Selective involvement with nonmalignant glands. Am J Surg Pathol, 1992, 16(10) : 975-981.
  • 5Gerstenbluth RE, Seftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up- regulation of bcl-2 in areas of inflammation. J Urol, 2002, 167 (5) : 2267-2270.
  • 6Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol, 2002, 167(3) : 1363-1366.
  • 7Delongchamps NB, de la Roza G, Chandan V, et al. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer.'? J Urol, 2008, 179(5): 1736-1740.
  • 8Konig JE, Senge T, Allhoff EP, et al. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate, 2004, 58(2): 121-129.
  • 9Mishra VC, Allen DJ, Nicolaou C, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007, 100(2) : 327-331.
  • 10Steiner G, Gessl A, Kramer G, et al. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J Urol, 1994, 15t(2) : 480-484.

共引文献117

同被引文献12

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部